2-Bromo-N,N-dimethylthiazole-5-carboxamide, 98%, 250mg

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(4-tert-butylphenyl)prop-2-en-1-one, 95.0%, 2g

METHYL N-BOC-2-OXOPIPERIDINE-3-CARBOXYLATE, 95.0%, 10g

Magnesium oxide 325 mesh, 96.0%, 100g

4-[(PYrazin-2-ylcarbonyl)amino]butanoic acid, 95%, 1g

Isobutylcyclohexane>98.0%(GC)25mL

Diethanolamine, min. 99%, for synthesis, 2.5 l, plastic packaging.

2,3,6-Trichlorobenzoic acid, 98%, 5g

3-Cyclobutene-1,2-dione, 3-[[(1S,2S)-2-aminocyclohexyl]amino]-4-[[3,5-bis(trifluoromethyl)phenyl]amino]-, 97%, 100mg

1-(2,2-Dimethylpropyl)cyclopropyl amine hydrochloride, 95.0%, 250mg

3-Bromo-1-triisopropylsilyl pyrrole, 97%, 5g

3-Propoxypicolinimidamide hydrochloride, 95.0%, 1g

1-(DIPHENYLMETHYL)-1H-INDOLE-2,3-DIONE, 95.0%, 250mg